Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
Efe Eworuke, Laura Hou, Rongmei Zhang, Hui‐Lee Wong, Peter Waldron, Abby Anderson, Audrey Gassman, David Moeny, Ting‐Ying Huang
Topics & Concepts
MedicineApixabanRivaroxabanDabigatranWarfarinHazard ratioAtrial fibrillationRetrospective cohort studyInternal medicineAnesthesiaConfidence intervalUterine Myomas and TreatmentsMaternal and fetal healthcareBlood Coagulation and Thrombosis Mechanisms